Wedmont Private Capital raised its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 26.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,623 shares of the health services provider’s stock after acquiring an additional 2,406 shares during the period. Wedmont Private Capital’s holdings in Cigna Group were worth $3,159,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. BlackRock Inc. increased its holdings in shares of Cigna Group by 3.7% during the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after purchasing an additional 840,098 shares during the period. GQG Partners LLC acquired a new stake in Cigna Group in the second quarter worth about $1,628,918,000. Bank of America Corp DE grew its position in Cigna Group by 8.8% in the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock valued at $848,821,000 after buying an additional 256,677 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its stake in Cigna Group by 9.8% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,958,656 shares of the health services provider’s stock valued at $814,311,000 after buying an additional 263,036 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Cigna Group by 10.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock valued at $647,008,000 after buying an additional 236,340 shares during the period. Institutional investors own 86.99% of the company’s stock.
Wall Street Analyst Weigh In
CI has been the subject of a number of research analyst reports. Guggenheim upped their price target on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Barclays upped their target price on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Robert W. Baird set a $362.00 price objective on Cigna Group in a research note on Friday, July 31st. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $337.00 target price on shares of Cigna Group in a research note on Thursday, October 1st. Finally, Sanford C. Bernstein reissued an “outperform” rating on shares of Cigna Group in a report on Friday, October 2nd. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $338.24.
Insider Buying and Selling
In related news, insider Everett Neville sold 617 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 22,730 shares of company stock worth $6,293,359 in the last 90 days. 0.60% of the stock is owned by company insiders.
Cigna Group Stock Performance
Shares of NYSE CI opened at $282.24 on Friday. The stock’s fifty day simple moving average is $277.41 and its 200 day simple moving average is $280.94. The stock has a market capitalization of $74.58 billion, a price-to-earnings ratio of 11.68, a PEG ratio of 0.95 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 52-week low of $239.51 and a 52-week high of $311.34.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $71.56 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. Cigna Group’s revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts forecast that Cigna Group will post 30.50 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th were given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is 25.82%.
Cigna Group Profile
The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.
Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.
Further Reading
- Five stocks we like better than Cigna Group
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
